These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25696592)

  • 1. Refractory hyperglycaemia induced by glucose-insulin-potassium infusion in acute myocardial infarction.
    Vogelzang M; Svilaas T; van der Horst IC; Nijsten MW; Zijlstra F
    Neth Heart J; 2006 Feb; 14(2):46-48. PubMed ID: 25696592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose and potassium derangements by glucose-insulin-potassium infusion in acute myocardial infarction.
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Miedema K; Gans RO; de Boer MJ; Vogelzang M; Nijsten MW; Zijlstra F
    Neth Heart J; 2006 Mar; 14(3):89-94. PubMed ID: 25696601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction.
    Zhang L; Zhang L; Li YH; Zhang HY; Chen ML; Gao MM; Hu AH; Yang HS; Yang HS
    Eur J Clin Invest; 2005 Mar; 35(3):164-70. PubMed ID: 15733070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative analysis of the effect of glucose-insulin-potassium in acute myocardial infarction.
    Rasoul S; Svilaas T; Ottervanger JP; Timmer JR; van 't Hof AW; Zijlstra F
    Neth Heart J; 2006 Jan; 14(1):19-23. PubMed ID: 25696550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential beneficial mechanisms of insulin (glucose-potassium) in acute myocardial infarction.
    van der Horst IC; Zijlstra F
    Neth Heart J; 2005 Jun; 13(6):233-238. PubMed ID: 25696497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
    Timmer JR; van der Horst IC; Ottervanger JP; De Luca G; van 't Hof AW; Bilo HJ; Zijlstra F
    Ital Heart J; 2004 Oct; 5(10):727-31. PubMed ID: 15626267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischaemia-reperfusion-induced damage.
    Bertuglia S; Giusti A; Fedele S; Picano E
    Diabetologia; 2001 Dec; 44(12):2165-70. PubMed ID: 11793017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
    Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
    JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction.
    Bedetti G; Pizzi C; Gabrieli L; Varga A; Pasanisi E; Bugiardini R; Picano E
    Int J Cardiol; 2005 Jul; 102(2):255-8. PubMed ID: 15982493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of low-dose dobutamine stress echocardiography and echocardiography during glucose-insulin-potassium infusion for detection of myocardial viability after anterior myocardial infarction.
    Yetkin E; Senen K; Ileri M; Atak R; Tandogan I; Yetkin O; Kosar F; Turhan H; Cehreli S
    Coron Artery Dis; 2002 May; 13(3):145-9. PubMed ID: 12131017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia.
    Di Marco S; Boldrini B; Conti U; Marcucci G; Morgantini C; Ferrannini E; Natali A
    Clin Sci (Lond); 2010 Apr; 119(1):37-44. PubMed ID: 20001969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
    Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
    JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.
    van der Horst IC; Zijlstra F; van 't Hof AW; Doggen CJ; de Boer MJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gans RO; Bilo HJ;
    J Am Coll Cardiol; 2003 Sep; 42(5):784-91. PubMed ID: 12957421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion.
    Rogers WJ; Stanley AW; Breinig JB; Prather JW; McDaniel HG; Moraski RE; Mantle JA; Russell RO; Rackley CE
    Am Heart J; 1976 Oct; 92(4):441-54. PubMed ID: 785990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616].
    van der Horst IC; Ottervanger JP; van 't Hof AW; Reiffers S; Miedema K; Hoorntje JC; Dambrink JH; Gosselink AT; Nijsten MW; Suryapranata H; de Boer MJ; Zijlstra F
    BMC Med; 2005 Jun; 3():9. PubMed ID: 15932638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II.
    Rasoul S; Ottervanger JP; Timmer JR; Svilaas T; Henriques JP; Dambrink JH; van der Horst IC; Zijlstra F
    Int J Cardiol; 2007 Oct; 122(1):52-5. PubMed ID: 17223212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction.
    Bucciarelli-Ducci C; Bianchi M; De Luca L; Battagliese A; Di Russo C; Proietti P; Vizza CD; Fedele F
    Am J Cardiol; 2006 Nov; 98(10):1349-53. PubMed ID: 17134627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
    Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.
    Pache J; Kastrati A; Mehilli J; Bollwein H; Ndrepepa G; Schühlen H; Martinoff S; Seyfarth M; Nekolla S; Dirschinger J; Schwaiger M; Schömig A
    Am Heart J; 2004 Jul; 148(1):e3. PubMed ID: 15215812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of high dose glucose-insulin-potassium infusion on myocardial injury and serum sFas/ sFasL concentration in acute myocardial infarction].
    Zhang L; Zhang L; Li YH; Chen ML; Zhang HY; Gao MM
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):499-502. PubMed ID: 16080838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.